S. Moein Moghimi

25.3k total citations · 6 hit papers
217 papers, 19.0k citations indexed

About

S. Moein Moghimi is a scholar working on Molecular Biology, Biomaterials and Immunology. According to data from OpenAlex, S. Moein Moghimi has authored 217 papers receiving a total of 19.0k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Molecular Biology, 81 papers in Biomaterials and 62 papers in Immunology. Recurrent topics in S. Moein Moghimi's work include Nanoparticle-Based Drug Delivery (75 papers), RNA Interference and Gene Delivery (48 papers) and Complement system in diseases (47 papers). S. Moein Moghimi is often cited by papers focused on Nanoparticle-Based Drug Delivery (75 papers), RNA Interference and Gene Delivery (48 papers) and Complement system in diseases (47 papers). S. Moein Moghimi collaborates with scholars based in United Kingdom, Denmark and United States. S. Moein Moghimi's co-authors include A. Christy Hunter, J. Clifford Murray, János Szebeni, Thomas L. Andresen, Dmitri Simberg, Linping Wu, Islam Hamad, S.S. Davis, Lisbeth Illum and Peter P. Wibroe and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

S. Moein Moghimi

215 papers receiving 18.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Circulating and Target-Specific Nanoparticles: Theory to Practice

2001 2.8k citations S. Moein Moghimi, A. Christy Hunter et al. profile →
Nanomedicine: current status and future prospects

2005 1.4k citations S. Moein Moghimi, A. Christy Hunter et al. profile →
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties

2003 932 citations S. Moein Moghimi, János Szebeni profile →
A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy

2005 930 citations S. Moein Moghimi, A. Christy Hunter et al. profile →
The Possible “Proton Sponge ” Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH

2012 604 citations S. Moein Moghimi et al. profile →
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo

2016 455 citations Guankui Wang, James I. Griffin et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Moein Moghimi United Kingdom	68	8.7k	8.4k	5.5k	2.6k	2.5k	217	19.0k
Mansoor M. Amiji United States	86	9.2k 1.1×	10.1k 1.2×	6.1k 1.1×	2.3k 0.9×	4.0k 1.6×	334	24.0k
Vinod Labhasetwar United States	61	8.4k 1.0×	7.0k 0.8×	5.4k 1.0×	2.9k 1.1×	3.8k 1.5×	148	18.9k
Qiang Zhang China	76	7.5k 0.9×	9.4k 1.1×	6.1k 1.1×	2.0k 0.8×	2.8k 1.1×	402	19.2k
Dan Peer Israel	57	7.5k 0.9×	9.7k 1.2×	6.7k 1.2×	2.5k 0.9×	989 0.4×	155	18.6k
Vladimir P. Torchilin United States	72	11.9k 1.4×	9.9k 1.2×	7.9k 1.4×	2.7k 1.0×	2.1k 0.8×	257	21.9k
Guanghui Ma China	78	6.2k 0.7×	7.0k 0.8×	8.2k 1.5×	6.2k 2.4×	2.8k 1.1×	531	22.8k
Jinming Gao United States	68	6.9k 0.8×	6.3k 0.8×	7.0k 1.3×	3.1k 1.2×	870 0.4×	173	17.8k
Zhirong Zhang China	75	6.0k 0.7×	8.2k 1.0×	5.3k 1.0×	1.5k 0.6×	3.4k 1.4×	525	19.1k
Véronique Préat Belgium	78	8.7k 1.0×	8.3k 1.0×	6.7k 1.2×	1.7k 0.7×	7.3k 3.0×	312	25.2k
Kwangmeyung Kim South Korea	88	11.2k 1.3×	10.0k 1.2×	12.1k 2.2×	4.8k 1.8×	2.3k 0.9×	381	25.8k

Countries citing papers authored by S. Moein Moghimi

Since Specialization

Citations

This map shows the geographic impact of S. Moein Moghimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Moein Moghimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Moein Moghimi more than expected).

Fields of papers citing papers by S. Moein Moghimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Moein Moghimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Moein Moghimi. The network helps show where S. Moein Moghimi may publish in the future.

Co-authorship network of co-authors of S. Moein Moghimi

This figure shows the co-authorship network connecting the top 25 collaborators of S. Moein Moghimi. A scholar is included among the top collaborators of S. Moein Moghimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Moein Moghimi. S. Moein Moghimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moghimi, S. Moein & Dmitri Simberg. (2025). Nanomedicine–lipoprotein interactions. Nature Reviews Bioengineering. 3(6). 435–437. 3 indexed citations

Li, Yue, Laura Saba, Robert I. Scheinman, et al.. (2024). Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts. ACS Nano. 18(42). 28649–28658. 9 indexed citations

Li, Yue, Hanmant Gaikwad, Andrew A. Monte, et al.. (2024). Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin. Molecular Pharmaceutics. 21(6). 3053–3060. 8 indexed citations

Yaghmur, Anan, et al.. (2023). Omega-3 fatty acid nanocarriers: Characterization and potential applications. Current Opinion in Colloid & Interface Science. 67. 101728–101728. 13 indexed citations

Moghimi, S. Moein & Simó Schwartz. (2022). Striking Circulating Tumour Cells during Sleep. SHILAP Revista de lepidopterología. 3(3). 132–133.

Lin, Jen-Hao, Hung-Chih Chen, Ray Putra Prajnamitra, et al.. (2022). PEGylation of Phosphatidylglycerol/Docosahexaenoic Acid Hexosomes with d-α-Tocopheryl Succinate Poly(ethylene glycol)₂₀₀₀ Induces Morphological Transformation into Vesicles with Prolonged Circulation Times. ACS Applied Materials & Interfaces. 14(43). 48449–48463. 16 indexed citations

Lau, Wing Man, et al.. (2021). Microneedle-based devices for point-of-care infectious disease diagnostics. Acta Pharmaceutica Sinica B. 11(8). 2344–2361. 65 indexed citations

Wu, Linping, Mario Ficker, Jørn B. Christensen, et al.. (2021). Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking. Nature Communications. 12(1). 4858–4858. 27 indexed citations

Andersen, Helene, Maxim Antopolsky, Anu J. Airaksinen, et al.. (2020). Hexosome engineering for targeting of regional lymph nodes. Materialia. 11. 100705–100705. 21 indexed citations

10.

Moghimi, S. Moein. (2020). The Journal of Nanotheranostics: A New Open-Access Journal at the Interface of Nanotechnology, Materials Science, and Medicine for Precision Medicine. 1(1). 56–57. 1 indexed citations

11.

Lau, Wing Man, et al.. (2020). The diagnostic potential of microneedles in infectious diseases. SHILAP Revista de lepidopterología. 3(3). 4 indexed citations

12.

Woythe, Laura, et al.. (2020). A structurally diverse library of glycerol monooleate/oleic acid non-lamellar liquid crystalline nanodispersions stabilized with nonionic methoxypoly(ethylene glycol) (mPEG)-lipids showing variable complement activation properties. Journal of Colloid and Interface Science. 582(Pt B). 906–917. 25 indexed citations

13.

Moghimi, S. Moein, Dmitri Simberg, Tore Skotland, Anan Yaghmur, & A. Christy Hunter. (2019). The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses. Journal of Pharmacology and Experimental Therapeutics. 370(3). 581–592. 52 indexed citations

14.

Wu, Linping, Davoud Ahmadvand, Arnaldur Hall, et al.. (2019). Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide. Nature Communications. 10(1). 4635–4635. 117 indexed citations

15.

Vu, Vivian, Fangfang Chen, Guankui Wang, et al.. (2018). Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Nature Nanotechnology. 14(3). 260–268. 243 indexed citations

16.

Moghimi, S. Moein & Dmitri Simberg. (2018). Nanoparticle transport pathways into tumors. Journal of Nanoparticle Research. 20(6). 169–169. 46 indexed citations

17.

Ng, Keng Wooi & S. Moein Moghimi. (2018). Skin Biosensing and Bioanalysis: what the Future Holds. SHILAP Revista de lepidopterología. 1(2). 124–127. 2 indexed citations

18.

Wibroe, Peter P., Aaron C. Anselmo, Per H. Nilsson, et al.. (2017). Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nature Nanotechnology. 12(6). 589–594. 165 indexed citations

19.

Griffin, James I., Guankui Wang, Vivian Vu, et al.. (2017). Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy. ACS Nano. 11(11). 11584–11593. 29 indexed citations

20.

Moghimi, S. Moein. (2006). Recent Developments in Polymeric Nanoparticle Engineering and Their Applications in Experimental and Clinical Oncology. Anti-Cancer Agents in Medicinal Chemistry. 6(6). 553–561. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact